Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality
Conclusions: Post-HD cfDNA level was superior to standard blood tests and could serve as a biomarker to assist in decision-making for HD-treated patients.Am J Nephrol
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Diabetes | Dialysis | Endocrinology | Hemodialysis | Neurology | Study | Urology & Nephrology